Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468838) titled 'Feasibility Study of Circulating Tumour DNA Analysis in Urine (Urinary cfDNA) as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer' on March 9.
Study Type: Observational [Patient Registry]
Primary Sponsor: Institut Cancerologie de l'Ouest
Condition:
Prostate Cancer
Bladder Cancer
Recruitment Status: Not recruiting
Date of First Enrollment: May 2026
Target Sample Size: 25
To know more, visit https://clinicaltrials.gov/study/NCT07468838
Disclaimer: Curated by HT Syndication....